"Melbourne Haematology - Monash Specialist Centre, Clayton. Clinical and laboratory trained haematologists providing comprehensive management for patients with haematological disorders. Our Haematologists include: Prof Stephen Opat, A/Prof Sanjeev Chunilal, A/Prof Huyen Tran, Dr James Griffiths, Dr Anna Kalff, Dr Zane Kaplan, Dr Gareth Gregory, Dr Michael Low, Dr Pasquale Fedele, Dr Shahla Vilcassim and Dr Agnes Yuen."

During the past decade, Monash Medical Centre; Haematology conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 4 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Monash Medical Centre; Haematology" #1 collaborator was "AbbVie" with 2 trials as a collaborator, "Fondazione Italiana Linfomi ONLUS" with 1 trials as a collaborator, "German CLL Study Group" with 1 trials as a collaborator, "German Low Grade Lymphoma Study Group" with 1 trials as a collaborator and "Institute of Cancer Research, United Kingdom" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Monash Medical Centre; Haematology" are "Chronic Lymphocytic Leukemia" (2 trials), "Chronic Lymphocytic Leukemia (CLL)" (1 trials), "Diffuse Large B-Cell Lymphoma" (1 trials), "Lymphocytic Leukemia, Chronic" (1 trials) and "Non-Hodgkin's Lymphoma" (1 trials). Many other conditions were trialed in "Monash Medical Centre; Haematology" in a lesser frequency.

Most popular intervention types in "Monash Medical Centre; Haematology" are "Drug" (6 trials). Other intervention types were less common.

The name of intervention was led by "Obinutuzumab" (4 trials), "Rituximab" (4 trials), "Bendamustine" (3 trials), "Cyclophosphamide" (3 trials) and "Venetoclax" (3 trials). Other intervention names were less common.

The vast majority of trials in "Monash Medical Centre; Haematology" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Monash Medical Centre; Haematology". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Monash Medical Centre; Haematology, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Monash Medical Centre; Haematology, 1 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".